CLOV

Reynoso Jamie L.

Known title: CEO, Medicare AdvantageCIK: 0001839066

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

Clover Health Gains After Earning 5-Star CMS Rating. Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.

this person other insiders at CLOV

Transaction History

CLOV▼ Sell$9K
CLOV▼ Sell$39K
CLOV▼ Sell$9K
CLOV▼ Sell$44K
CLOV▼ Sell$22K
CLOV▼ Sell$61K
CLOV▼ Sell$11K
CLOV▼ Sell$33K
CLOV▼ Sell$11K
CLOV▼ Sell$29K
CLOV▼ Sell$36K
CLOV▼ Sell$26K
CLOV▼ Sell$11K
CLOV▲ Buy$0
CLOV▼ Sell$11K
CLOV▼ Sell$12K
CLOV▼ Sell$18K
CLOV▼ Sell$12K
CLOV▼ Sell$41K
CLOV▼ Sell$5K
CLOV▼ Sell$20K
CLOV▼ Sell$13K
CLOV▼ Sell$23K
CLOV▼ Sell$34K
CLOV▼ Sell$109K
CLOV▼ Sell$360K
CLOV▼ Sell$104K
CLOV▼ Sell$44K
CLOV▼ Sell$200K
CLOV▼ Sell$5K
CLOV▼ Sell$23K
CLOV▼ Sell$15K
CLOV▼ Sell$27K
CLOV▼ Sell$38K
CLOV▼ Sell$20K
CLOV▼ Sell$85K
CLOV▼ Sell$6K
CLOV▼ Sell$51K
CLOV▼ Sell$22K
CLOV▲ Buy$0
CLOV▼ Sell$239K
CLOV▼ Sell$58K
CLOV▼ Sell$25K
CLOV▼ Sell$36K
CLOV▼ Sell$87K
CLOV▼ Sell$22K
CLOV▼ Sell$23K
CLOV▼ Sell$34K
CLOV▼ Sell$95K
CLOV▼ Sell$62K
CLOV▼ Sell$27K
CLOV▼ Sell$27K
CLOV▼ Sell$39K
CLOV▼ Sell$486K
CLOV▲ Buy$0
CLOV▼ Sell$35K
CLOV▼ Sell$26K
CLOV▼ Sell$38K
CLOV▲ Buy$0
CLOV▼ Sell$305K
CLOV▼ Sell$7K
CLOV▲ Buy$0
CLOV▼ Sell$65K
CLOV▼ Sell$6K
CLOV▼ Sell$8K
CLOV▼ Sell$4K
CLOV▼ Sell$4K
CLOV▼ Sell$6K
CLOV▼ Sell$16K
CLOV▼ Sell$24K
CLOV▼ Sell$1K
CLOV▼ Sell$9K
CLOV▼ Sell$13K
CLOV▲ Buy$0
CLOV▼ Sell$24K
CLOV▼ Sell$9K
CLOV▲ Buy$0
CLOV▼ Sell$69K
CLOV▼ Sell$7K
CLOV▼ Sell$29K
CLOV▼ Sell$2K
CLOV▼ Sell$17K
CLOV▲ Buy$0
CLOV▲ Buy$0
CLOV▲ Buy$0
CLOV▲ Buy$0
CLOV▼ Sell$50K

We use analytics to understand how market-wall is used. No personal data is sold.